Pharmacological interventions for epilepsy in people with intellectual disabilities

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Beavis, Janine ^a   Kerr, Michael ^a   Marson, Anthony G ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Lower Lane   (United Kingdom)

Author keywords

*Mentally disabled persons; Anticonvulsants adverse effects; *therapeutic use ; Epilepsy *drug therapy ; Humans; Randomized controlled trials as topic

Indexed keywords

AMRINONE; DOPAMINE; DOPEXAMINE; GANTAILE; HERBACEOUS AGENT; LIVER PROTECTIVE AGENT; PENTOXIFYLLINE; PROPOFOL; PROSTAGLANDIN E1; PROTEINASE INHIBITOR; SEVOFLURANE; ULINASTATIN; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; BILE LEAKAGE; BLEEDING; BLOOD TRANSFUSION; CHINESE MEDICINE; ELECTIVE SURGERY; HERBAL MEDICINE; HUMAN; LENGTH OF STAY; LIVER FAILURE; LIVER FUNCTION; LIVER ISCHEMIA; LIVER RESECTION; LIVER SURGERY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; REPERFUSION INJURY; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WOUND INFECTION;

EID: 77950220358     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Battaglia 1991 {published data only} Battaglia A, Ferrari AR, Guerrini, R. Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy. Brain & Development 1991;13(4):217-22.
2. Crawford 2001 {published data only} Crawford P, Brown S, Kerr M, Parke Davis Clinical Trials Group. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy. Seizure 2001;10(2):107-15.
3. Crumrine 1989 {published data only} Crumrine P, Dreifuss FE, Corwin H, et al.Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome. Epilepsia 1989;30(4): 422-9.
4. Eriksson 1998 {published data only} Eriksson AS, Nergardh A, Hoppu, K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia 1998;39(5):495-501.
5. Gigli 1988 {published data only} Gigli GL, Mazza S, Valente RM, Colognola RM, Musumeci R. Inefficacia dell'aggiunta di flunarizina al trattamento di pazienti con epilessia e ritardo mental: risultati di uno studio cross-over in doppio cieco [Ineffectiveness of add-on treatment with Flunarizine in patients with epilepsy and mental retardation]. Il Bolletino della Lega Italiana contro l'Epilessia 1988;62(63):417-418.
6. Kaski 1991 {published data only} Kaski M, Heinonen E, Sivenius J, et al.Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. Journal of Mental Deficiency Research 1991;35(3):231-9.
7. Kerr 2005 {published data only} Kerr MP, Baker GA, Brodie MJ. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy & Behavior 2005;7(3):472-80.
8. Motte 1997 {published data only} Motte J, Trevathan E, Arvidsson JFV, et al.Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. New England Journal of Medicine 1997;337(25):1807-12.
9. Ritter 1993 {published data only} Ritter FJ, Leppik IE, Dreifuss FE, et al.Efficacy of felbamate in childhood epileptic encephalopathy (Lennox- Gastaut syndrome). New England Journal of Medicine 1993;328(1):29-33.
10. Sachdeo 1999 {published data only} Sachdeo RC, Glauser TA, Ritter F, et al.A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999;52(9):1882-7.
11. Siegel 1999 {published data only} Siegel H, Kelley K, Stertz B, et al.The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome. Epilepsy Research 1999;34(2-3):91-7.
12. Yamatogi 1997 {published data only} Yamatogi Y, Ohtahara S, Shigematsu H, et al.Single blind comparative study of clobazam (NH-15) with clonazepam in intractable childhood epilepsies. Journal of the Japan Epilepsy Society 1997;15(2):110-21.
13. Bielmann 1978 {published data only} Bielmann P, Levac T, Gagnon MA. Clonazepam: its efficacy in association with phenytoin and phenobarbital in mental patients with generalized major motor seizures. International Journal of Clinical Pharmacology and Biopharmacy 1978;16(6):268-73.
14. Billard 1996 {published data only}
15. Espe-Lillo 1992 {published data only} Espe-Lillo J, Ritter FJ. Long-term follow-up of felbamate treatment in children with Lennox-Gastaut Syndrome. Epilepsia 1992;33(Suppl 3):118.
16. Glauser 1997 {published data only} Jensen PK. Felbamate in the treatment of Lennox-Gastaut syndrome.. Epilepsia 1994;35(Suppl 5):S54-7.
17. Jensen 1994 {published data only}
18. Luna {published data only}
19. Mullens 1996 {published data only}
20. Oletsky 1996 {published data only}
21. Ritter 1991 {published data only}
22. Schlumberger {published data only}
23. Smith 1968 {published data only} Smith WL, Philippus MJ, Guard HL. Psychometric study of children with learning problems and 14-6 positive spike EEG patterns, treated with ethosuximide (Zarontin) and placebo. Archives of Disease in Childhood 1968;43(231):616-9.
24. Turner 1970 {published data only} Turner M, Cordero Funes JR, Aspinwall R, et al.Clinicoelectroencephalographic evaluation of a new benzodiazepine (Ro 05-4023) by oral administration in epileptic patients by double blind technique. Acta Neurologica Latinoamericana 1970;16(1):158-69.
25. Vigevano 1994 {published data only}
26. 1981 Commission on Classification and Terminology of the ILAE: Proposal for revised clinical and EEG classification of epileptic seizures. Epilepsia 1981;22:489-501.
27. 1989 Commission on Classification and Terminology of the ILAE: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
28. Beran 1998 Beran RG, Gibson RJ. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 1998;39(3):280-2.
29. Besag 2001 Besag FM. Behavioural effects of the new anticonvulsants.. Drug Safety 2001;24(7):513-36.
30. Bouras 1992 Bouras N, Drummond C. Behaviour and psychiatric disorders of people with mental handicaps living in the community. Journal of Intellectual Disability Research 1992;36(4):349-57.
31. Bowley 2000 Bowley C, Kerr M. Epilepsy And Intellectual Disability. Journal Of Intellectual Disability Research 2000;44(5):529-43.
32. Dam 1990 Dam M. Vigabatrin and behaviour disturbances (Letter). Lancet 1990;335:8689.
33. Deb 1991 Deb S, Hunter D. Psychopathology of people with mental handicap and epilepsy. I: Maladaptive behaviour. British Journal of Psychiatry 1991;159:822-6.
34. Deb 1997 Deb S. Mental disorder in adults with mental retardation and epilepsy. Comprehensive Psychiatry 1997;38(3):179-84.
35. Deb 1998 Deb S, Joyce J. Psychiatric illness and behavioural problems in adults with learning disability and epilepsy. Behavioural Neurology 1998;11(3):125-129.
36. Deb 1999 Deb S, Joyce J. Characteristics of epilepsy in a population based cohort of adults with learning disability. Irish Journal of Psychological Medicine 1999;16(1):5-9.
37. Dulac 1991 Dulac O, Chiron C, Luna D, Cusmai R, Pajot N, Beaumont D, Mondragon S. Vigabatrin in childhood epilepsy. Journal of Child Neurology 1991;6(Suppl 2):S30-7.
38. Eaton 1982 Eaton LF, Menolascino FJ. Psychiatric disorders in the mentally retarded: Types, problems, and challenges. American Journal of Psychiatry 1982;139(10):1297-1303.
39. Espie 1989 Espie CA, Pashley AS, Bonham KG, Sourindhrin I, O'Donovan M. The mentally handicapped person with epilepsy: A comparative study investigating psychosocial functioning. Journal of Mental Deficiency Research 1989;33(2):123-35.
40. Espie 1990 Espie CA, Gillies JB,Montgomery JM. Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community. Journal of Mental Deficiency Research 1990;34(4):351-60.
41. Ettinger 1998 Ettinger AB, Weisbrot DM, Saracco J, Dhoon A, Kanner A, Devinsky O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998;39(8):874-7.
42. Forsgren 1990 Forsgren L, Edvinsson SO, Blomquist HK, Heijbel J, Sidenvall R. Epilepsy in a population of mentally retarded children and adults. Epilepsy Research 1990;6(3):234-48.
43. Gay 1995 Gay PE, Mecham GF, Coskey JS, Sadler T, Thompson JA. Behavioural effects of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Psychological Reports 1995;77(3 Pt 2):1208-10.
44. Gillies 1989 Gillies JB, Espie CA, Montgomery JM. The social and behavioural functioning of people with mental handicaps attending adult training centres: a comparison with thosewith and without epilepsy. Mental Handicap Research 1989;2:129-36.
45. Goulden 1991 Goulden K, Shinnar S, Koller H, Katz M, Richardson S. Epilepsy in children with mental retardation: a cohort study. Epilepsia 1991;34:690-7.
46. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database of Systematic Reviews 2005, Issue 3.
47. Hoare 1984 Hoare P. The development of psychiatric disorder among school children with epilepsy. Developmental Medicine and Child Neurology 1984;26(1):3-13.
48. Khurana 1996 Khurana DS, Riviello J, Helmers S, Holmes G, Anderson J, Mikati MA. Efficacy of gabapentin therapy in children with refractory partial seizures. Journal of Pediatrics 1996;128(6):829-33.
49. Lee 1996 Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ, Mikati MA. Behavioral side effects of gabapentin in children. Epilepsia 1996;37(1):87-90.
50. Lund 1985 Lund J. Epilepsy and psychiatric disorder in the mentally retarded adult. Acta Psychiatrica Scandinavica 1985;72(6):557-62.
51. Mansell 1993 Mansell JL. Services for People with Learning Disabilities and Challenging Behaviour or Mental Health Needs. London: HMSO, 1993.
52. Mariani 1993 Mariani E, Ferini-Strambi L, Sala M, Erminio C, Smirne S. Epilepsy in institutionalized patients with encephalopathy: clinical aspects and nosological considerations. American Journal of Mental Retardation 1993;98:27-33.
53. Mikati 1998 Mikati MA, Choueri R, Khurana DS, Riviello J, Helmers S, Holmes G. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability. Journal of Intellectual Disability Research 1998;1:57-62.
54. Morgan 2003 Morgan CL, Baxter H, Kerr MP. Prevalence of epilepsy and associated health service utilization and mortality among patients with intellectual disability. American Journal of Mental Retardation 2003;108(5):293-300.
55. Mullens 1996 Mullens L, Gallagher J, Manasco P. Improved neurological function accompanies effective control of the Lennox-Gastaut syndrome with Lamictal: results of a multinational, placebo-controlled trial [abstract]. Epilepsia 1996;37:163.
56. Sackett 1997 Sackett DL, Richardson WS, Rosenberg W, Haynes BR. Evidence-Based Medicine: How to Practice and Teach EBM. Edinburgh: Churchill, Livingstone, 1997.
57. Shepherd 1989 Shepherd C, Hosking G. Epilepsy in school children with intellectual impairments in Sheffield: the size and nature of the problem and its implications in service provision. Journal of Mental Dificiency Research 1989;33:511-4.
58. Stafstrom 1993 Stafstrom C. Epilepsy in Down's syndrome: clinical aspects and possible mechanisms. American Journal of Mental Retardation 1993;98:12-26.
59. Wallace 1996 Wallace SJ. A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Safety 1996;15(6):378-93.
60. Webb 1991 Webb D, Fryer A, Osborne J. On the incidence of fits and mental retardation in tuberous sclersosis. Journal of Medical Genetics 1991;6:395-7.
61. Wolf 1995 Wolf SM, Shinnar S, Kang H, Gil KB, Moshe SL. Gabapentin toxicity in children manifesting as behavioural changes. Epilepsia 1995;36(12):1203-5.